221 related articles for article (PubMed ID: 32662449)
21. A European Respiratory Society technical standard: exhaled biomarkers in lung disease.
Horváth I; Barnes PJ; Loukides S; Sterk PJ; Högman M; Olin AC; Amann A; Antus B; Baraldi E; Bikov A; Boots AW; Bos LD; Brinkman P; Bucca C; Carpagnano GE; Corradi M; Cristescu S; de Jongste JC; Dinh-Xuan AT; Dompeling E; Fens N; Fowler S; Hohlfeld JM; Holz O; Jöbsis Q; Van De Kant K; Knobel HH; Kostikas K; Lehtimäki L; Lundberg J; Montuschi P; Van Muylem A; Pennazza G; Reinhold P; Ricciardolo FLM; Rosias P; Santonico M; van der Schee MP; van Schooten FJ; Spanevello A; Tonia T; Vink TJ
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446552
[TBL] [Abstract][Full Text] [Related]
22. Diabetes noninvasive diagnostics and monitoring through volatile biomarkers analysis in the exhaled breath using optical absorption spectroscopy.
Kistenev YV; Borisov AV; Zasedatel VS; Spirina LV
J Biophotonics; 2023 Dec; 16(12):e202300198. PubMed ID: 37643222
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular biomarkers in exhaled breath.
Cikach FS; Dweik RA
Prog Cardiovasc Dis; 2012; 55(1):34-43. PubMed ID: 22824108
[TBL] [Abstract][Full Text] [Related]
24. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P
J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264
[TBL] [Abstract][Full Text] [Related]
25. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
26. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.
van de Kant KD; van der Sande LJ; Jöbsis Q; van Schayck OC; Dompeling E
Respir Res; 2012 Dec; 13(1):117. PubMed ID: 23259710
[TBL] [Abstract][Full Text] [Related]
27. Exhaled breath analysis by electronic nose in respiratory diseases.
Scarlata S; Pennazza G; Santonico M; Pedone C; Antonelli Incalzi R
Expert Rev Mol Diagn; 2015; 15(7):933-56. PubMed ID: 25959642
[TBL] [Abstract][Full Text] [Related]
28. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of breath analysis and detection of volatile organic compounds in COPD.
Christiansen A; Davidsen JR; Titlestad I; Vestbo J; Baumbach J
J Breath Res; 2016 Aug; 10(3):034002. PubMed ID: 27578038
[TBL] [Abstract][Full Text] [Related]
30. Exhaled volatile organic compounds in adult asthma: a systematic review.
Azim A; Barber C; Dennison P; Riley J; Howarth P
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31273044
[TBL] [Abstract][Full Text] [Related]
31. Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: A pilot study.
Thomas JN; Roopkumar J; Patel T
PLoS One; 2021; 16(11):e0260098. PubMed ID: 34847181
[TBL] [Abstract][Full Text] [Related]
32. Establishing breath as a biomarker platform-take home messages from the Breath Biopsy Conference 2023.
Chou H; Godbeer L; Ball ML
J Breath Res; 2024 Apr; 18(3):. PubMed ID: 38631337
[TBL] [Abstract][Full Text] [Related]
33. Potential of Mass Spectrometry in Developing Clinical Laboratory Biomarkers of Nonvolatiles in Exhaled Breath.
Beck O; Olin AC; Mirgorodskaya E
Clin Chem; 2016 Jan; 62(1):84-91. PubMed ID: 26578691
[TBL] [Abstract][Full Text] [Related]
34. Immediate effects of breath holding maneuvers onto composition of exhaled breath.
Sukul P; Trefz P; Schubert JK; Miekisch W
J Breath Res; 2014 Sep; 8(3):037102. PubMed ID: 25189647
[TBL] [Abstract][Full Text] [Related]
35. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath.
Gahleitner F; Guallar-Hoyas C; Beardsmore CS; Pandya HC; Thomas CP
Bioanalysis; 2013 Sep; 5(18):2239-47. PubMed ID: 24053239
[TBL] [Abstract][Full Text] [Related]
36. Optimisation of sampling parameters for standardised exhaled breath sampling.
Doran SLF; Romano A; Hanna GB
J Breath Res; 2017 Dec; 12(1):016007. PubMed ID: 29211685
[TBL] [Abstract][Full Text] [Related]
37. The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review.
Terrington DL; Hayton C; Peel A; Fowler SJ; Fraser W; Wilson AM
J Breath Res; 2019 Jun; 13(3):036015. PubMed ID: 30901768
[TBL] [Abstract][Full Text] [Related]
38. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
39. Modeling-based determination of physiological parameters of systemic VOCs by breath gas analysis, part 2.
Ager C; Unterkofler K; Mochalski P; Teschl S; Teschl G; Mayhew CA; King J
J Breath Res; 2018 Apr; 12(3):036011. PubMed ID: 29488464
[TBL] [Abstract][Full Text] [Related]
40. Factors that influence the volatile organic compound content in human breath.
Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
